As indicated above, identification of iNOS/NO signaling for a survival, proliferative, and migratory/invasive advantage in tumor cells is typically based on the suppressing effects of specific inhibitors of iNOS activity (1400W, GW274150) or NO scavengers (e.g., cPTIO). The gene discussed is NOS2; the disease is neoplasm.